Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219

NCT01903005 is registered in ClinicalTrials.gov with Orexo AB as lead sponsor.

NCT NCT01903005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01903005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Lead sponsor
Orexo AB
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
September 30, 2014
Enrollment
668 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

opioid dependence, on agonist therapy